Drugs.com

AUGUST 16, 2023

Breast cancer accounted for the most cases in adults under 50 between 2010 and 2019, but. WEDNESDAY, Aug. 16, 2023 -- Breast, colon and pancreatic cancer rates are increasing at concerning rates among America's young adults, a new study finds.

189

189

SCIENMAG: Medicine & Health

JULY 14, 2023

billion in project funding for phased clinical trials involving drugs approved by the FDA from 2010-2019, according to a new study from Bentley University’s Center for Integration of Science and Industry. BENTLEY UNIVERSITY Credit: Bentley University BENTLEY UNIVERSITY The U.S. National Institutes of Health (NIH) contributed $8.1

Clinical Trials 77

Clinical Trials Trials Drugs FDA 77

Science Daily: Pharmacology News

JUNE 8, 2023

C between 2010 and 2019. Human-induced warming, largely caused by the burning of fossil fuels, reached an average of 1.14°C C for the most recent decade (2013 to 2022) above pre-industrial levels. This is up from 1.07°C Human-induced warming is now increasing at a pace of over 0.2°C C per decade.

194

194

Science Daily: Pharmacology News

OCTOBER 23, 2024

A recovery program increased their population by 2010, but from 2014 to 2018, it fell to 30% of its peak due to a new acanthocephalan parasite, exacerbated by a prolonged drought. In the 1990s, the San Miguel Island fox nearly went extinct, with numbers dropping to just 15.

Research 147

Research 147

Reprocell

JUNE 10, 2025

REPROCELL has led the way in mRNA reprogramming, in 2010 becoming the first company to commercialize mRNA-based reprogramming technologies. The Power of mRNA Reprogramming The emergence of mRNA reprogramming offers a precise, efficient, and xeno-free approach to generating induced pluripotent stem cells (iPSCs).

Therapies 52

Therapies Disease Research Drugs 52

Drug Patent Watch

JULY 27, 2023

Here’s a summary of a new article that used DrugPatentWatch data: NIH Funding for Patents That Contribute to Market Exclusivity of Drugs Approved 2010–2019 and the Public Interest Protections of… The post DrugPatentWatch reveals NIH funding for patents appeared first on DrugPatentWatch - Make Better Decisions.

Marketing 92

Marketing Drugs 92

Drug Target Review

JUNE 6, 2025

RMX initiated the first IND for Lu-177 dotatate in the US for NETs at Excel Diagnostic Oncology Center, where we treated our first patient in August 2010,” he recalls. He references early work from Erasmus University in the 2000s as a turning point, where researchers were targeting NETs using lutetium-177 dotatate (Lu-177).

Therapies 100

Therapies Treatment Drug Development Clinical Development 100

SCIENMAG: Medicine & Health

AUGUST 4, 2023

Since its inception in 2010, the program bolsters national scientific […] of Energy The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.

Research 89

Research Laboratories Science 89

SCIENMAG: Medicine & Health

AUGUST 20, 2023

In September 2010, China’s manned space station project […] As a manned spacecraft operating in orbit for a long time, a space station embodies a country’s scientific and technological strength comprehensively.

Science 85

Science 85

SCIENMAG: Medicine & Health

AUGUST 21, 2023

In 2010, the U.S. government announced a multi-billion-dollar plan to improve the energy efficiency of its buildings, including a focus on LEED certification. Used worldwide, LEED—Leadership in Energy and Environmental Design—is a system that rates buildings on energy efficiency.

Government 69

Government 69

Drug Target Review

FEBRUARY 2, 2024

In summary, all these factors can affect the response to drugs and drug target manipulation.

Drugs 116

Drugs Clinical Trials Disease Science 116

FDA Law Blog: Biosimilars

AUGUST 12, 2024

In February 2010, an oral formulation of BRAVECTO, a medication to treat and prevent fleas and tick infestation in dogs, was the subject of an INAD submitted to the Agency. With this decision, the testing phase for BRAVECTO began on February 19, 2010, giving Plaintiffs an additional year to be included in its testing phase calculations.

FDA 59

FDA Regulations FDA Approval Drugs 59

SCIENMAG: Medicine & Health

JULY 19, 2023

Using an innovative method for measuring doctor turnover, Weill Cornell Medicine researchers determined that between 2010 and 2018, the annual rate at which physicians left their practices increased by 43 percent, from 5.3 percent to 7.6 percent a year.

Doctors 65

Doctors Research 65

The Pharma Data

JANUARY 13, 2021

13, 2021 — From 2010 to 2017, there were significant increases in the estimated rates of neonatal abstinence syndrome (NAS) and maternal opioid-related diagnoses (MOD), according to a study published in the Jan. per 1,000 birth hospitalizations from 2010 to 2017. WEDNESDAY, Jan. Hirai, Ph.D., Hirai, Ph.D., in Nebraska to 47.3

Hospitals 52

Hospitals Research 52

Common Sense for Drug Policy Blog

JULY 2, 2025

While the proportion exceeding the single occasion risk and lifetime risk guidelines has remained stable in recent years, it has improved since the guidelines were introduced in 2009 (was 29% and 21% respectively in 2010)." dwf_admin Wed, 07/02/2025 - 15:57 Source Australian Institute of Health and Welfare 2020. Drug Statistics series no.

Drugs 52

Drugs 52

Drug Target Review

APRIL 4, 2024

In 2010 he was appointed Executive Vice President, Research at NeuroSearch. During the years 2007-2010 he served as board member of SwedenBIO, the Swedish Biotech industry association. In 2006, Carlsson Research was sold to NeuroSearch and changed name to NeuroSearch Sweden. In 2013, Nicholas co-founded IRLAB Sweden.

Disease 105

Disease Treatment Licensing Licensing 105

Broad Institute

MARCH 8, 2024

To address this obstacle, the Broad Institute established the Next Generation Awards in 2010 with the support of an extremely generous philanthropic gift. Hung (2010 - 2011 awardee) James Bradner Jake Jaffe 2011 - 2012 Awardees Feng Zhang John Rinn Mitchell Guttman Anne Carpenter 2010 - 2011 Awardees Deborah T.

Research 52

Research 52

biobide

SEPTEMBER 29, 2023

Zebrafish embryofr are in the middle term between in vitro and in vivo models offering the complexity of a whole organism but in an organism that is not considered an experimental animal by European law (EU Directive 2010/63/EU), until the 5-6 days post fertilization (dpf) when they start feeding independently.

Animal Testing 106

Animal Testing Drugs Pharmacokinetics Regulations 106

Perficient: Drug Development

MARCH 22, 2024

–[if gt mso 14]> Everything above Outlook 2010 <![endif]–> –[if lt mso 14]> Everything below Outlook 2010 <![endif]–> –[if gte mso 14]> Outlook 2010 and above <![endif]–> –[if lte mso 14]> Outlook 2010 and below <![endif]–>

52

52

Broad Institute

JANUARY 25, 2024

Unlike previous studies that searched for genes associated with overall retina health, this study delved deeper into the role of the different cell layers that make up the retina.

Disease 124

Disease Research Science Medical Schools 124

New Drug Approvals

SEPTEMBER 6, 2024

11:373-384 (2010)). 10:89-102 (2010)). The Toll-like receptor family recognizes molecular patterns derived from infectious organisms including bacteria, fungi, parasites, and viruses (reviewed in Kawai, T. Nature Immunol., With the exception of TLR3, all TLRs recruit the adaptor molecule MyD88. Nature Rev.

RNA 62

RNA Clinical Trials DNA Disease 62

FDA Law Blog: Biosimilars

APRIL 17, 2024

Drug Take Back Days have made appearances each spring and autumn since 2010. Events over the years have led to the removal of more than 17.9 million pounds of unwanted medication across the country. Last October’s Drug Take Back Day removed 600,000 pounds (300 tons) of medication at almost 4,700 collection sites.

Drugs 59

Drugs 59

Drug Target Review

JULY 7, 2025

European Directive 2010/63/EU on the protection of animals used for scientific purposes. References Animal Legal Defense Fund v. USDA (2020). Federal ruling on USDA primate welfare petition, 2023. National Research Council. Guide for the Care and Use of Laboratory Animals. NIH Office of Laboratory Animal Welfare – Training Guidelines.

Drug Research 52

Drug Research Research Animal Testing Drugs 52

Agency IQ

AUGUST 25, 2023

Regulatory Context: Biosimilars and Interchangeability The FDA was first authorized to develop a pathway for the approval of biosimilar products in 2010 under the Biologics Price Competition and Innovation (BPCI) Act. While the exact contents of this guidance are unclear, prior FDA labeling guidance may offer some clues as to FDA’s approach.

Biosimilars 52

Biosimilars FDA Production 52

The Pharma Data

DECEMBER 8, 2020

The context and research base has greatly evolved since 2010 – over 100 new studies – across a wider array of health worker occupations and countries now form the evidence base.

Research 52

Research 52

LifeSciVC

DECEMBER 5, 2024

When I joined in 2005, the “patient” (Atlas) was undergoing surgery and we came out of the decade in 2010 with a small partnership, around one table, in one office in Cambridge. In 2014, we simplified further by focusing Atlas only on biotech.

Marketing 84

Marketing RNA Drugs Science 84

Broad Institute

JUNE 8, 2010

By admin June 8, 2010 Link Primer3 Topic Primer Design Sequence Analysis Primer3 Primer3 is a tool used to choose primers for PCR reactions.

40

40

Eye on FDA

AUGUST 2, 2022

By 2002, the number had dropped to 28, reviving somewhat by the end of that decade when it reached 52 in 2010. But when it comes to enforcement things have changed greatly over the years. In 1998, there were 156 letters issued in a single year. So far this year, we are at 4, which is a pretty good clip these days.

Pharmaceutical Companies 88

Pharmaceutical Companies FDA Pharmaceuticals Drugs 88

NIH Director's Blog: Drug Development

FEBRUARY 27, 2018

In an analysis of more than 28 million papers in the PubMed.gov database , researchers found NIH contributed to published research that was associated with every single one of the 210 new drugs approved by the Food and Drug Administration from 2010 through 2016 [1]. Reference: [1] Contribution of NIH funding to new drug approvals 2010-2016.

Research 52

Research Science FDA Pharmaceutical Companies 52

The Pharma Data

JANUARY 12, 2021

The study focused solely on GoFundMe fundraisers, extracting data between May 2010 (when the site began) and December 2018. The researchers found 42 fundraisers for medical conditions in 2010 and 119,373 in 2018, a number that rose incrementally through the years. “We know that health care in the U.S.

Treatment 52

Treatment International Research Therapies 52

Broad Institute

JUNE 8, 2010

By admin June 8, 2010 Link Gene Set Enrichment Analysis Topic Expression Analysis Pathway Analysis mutation significance Gene Set Enrichment Analysis GSEA is a computational method that determines whether an a priori defined set of genes shows statistically significant, concordant differences between two biological states (e.g. phenotypes).

40

40

Common Sense for Drug Policy Blog

JULY 8, 2023

operated by the Commissions) and, in particular, trends from 2010 to 2019, also registered a global increase [ 27 ]. The increase of punitive responses raises the question of what happened in Portugal during the last decade and what is the actual role played by the Supreme Court judgment of 2008. Administrative sanctions (i.e.,

Drugs 52

Drugs 52

Drug Target Review

NOVEMBER 17, 2023

Dr Huimin Cao Senior Research Fellow, Cartherics Dr Madeline Cao received her MD in 2010 and practiced at Institute of Hematology & Blood Diseases Hospital in Tianjin, China. Alan is Emeritus Professor Monash University and Distinguished Scientist, Hudson Institute for Medical Research, Clayton, Victoria, Australia.

Therapies 118

Therapies Clinical Trials Cell Biology Trials 118

The Pharma Data

NOVEMBER 23, 2020

Dietary information was collected at baseline (1993 to 2001) and follow-up (around 2010). Tong, Ph.D., from the University of Oxford in the United Kingdom, and colleagues conducted a prospective study to examine differences in fracture risks between vegetarians, vegans, and nonvegetarians.

Research 52

Research 52

Broad Institute

JUNE 8, 2010

By admin June 8, 2010 Link Connectivity Map Topic Expression Analysis Annotation Portals CMap perturbations Gene Expression Broad tags Cancer Program Cancer Todd Golub This web interface is designed to allow biologists, pharmacologists, chemists, and clinical scientists to use our analysis tools and access the raw data.

Small Molecule 40

Small Molecule Disease Drugs 40

Eye on FDA

JUNE 14, 2023

Back to Enforcement – At nearly the same time OPDP launched the “Bad Ad” program (2010) which is designed to deputize healthcare professionals and others to spotting and reporting potentially non-compliant communications, enforcement began to diminish. Not a huge pool from which to pull, but indicative nonetheless.

FDA 82

FDA Production Doctors Treatment 82

The Pharma Data

DECEMBER 29, 2020

from Odense University Hospital in Esbjerg, Denmark, and colleagues used the Danish Hip Arthroplasty Register to identify 31,105 primary THAs indicated for primary osteoarthritis performed from 2010 to 2014 with two years of follow-up data to assess the cumulative incidence of hip dislocation (revisions and closed reductions) after primary THA.

Hospitals 52

Hospitals Research 52